Literature DB >> 3079083

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.

A B Cosimi1, S I Cho, F L Delmonico, M M Kaplan, R J Rohrer, R L Jenkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3079083

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts.

Authors:  Jing Li; Bo Zhou; Jianzhong Shentu; Li Du; Min Tan; Sheng Hou; Weizhu Qian; Bohua Li; Dapeng Zhang; Jianxin Dai; Hao Wang; Xu Zhang; Jianghua Chen; Yajun Guo
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  Effect of OKT3 on survival and rate of retransplantation.

Authors:  B H Markus; J J Fung; R D Gordon; S Iwatsuki; C O Esquivel; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.